HEART-FAILURE - AN UPDATE ON PATHOPHYSIOLOGY

被引:0
|
作者
DREXLER, H
机构
关键词
HEART FAILURE; PATHOPHYSIOLOGY; PERIPHERAL ADAPTATION; ANGIOTENSIN-II;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Myocardial hypertrophy is an established risk factor for cardiovascular morbidity and mortality. Beyond quantitative and mechanical aspects hypertrophy is associated with alterations in cardiac gene expression, resulting in a more fetal-like myocyte phenotype with a fragile Ca++ homeostasis. Depressed expression of sarcoplasmatic reticulum ATPase is the hallmark of this overload phenotype. Conversely, the gene expression and the activity of sodium calcium exchanger is up-regulated in endstage heart failure. Both alterations contribute to prolonged cytosolic Ca++ transients, disturbed relaxation and, probably, to electrophysiologic instability. Angiotensin II is a growth promoting agent and several lines of circumferential evidence suggest that the local formation of angiotensin II might contribute to the trophic response and phenotype shift, in cardiac overload. The cardiac gene expression of angiotensin converting enzyme and angiotensinogen is increased early after cardiac overload and in patients with severe heart failure. Chronic ACE inhibition suppresses plasma and tissue ACE activity, reduces LV hypertrophy and improves long-term survival. The hallmark of the peripheral adaptation in chronic heart failure is systemic vasoconstriction, associated with neurohumoral activation. Several mechanisms are involved in the impaired peripheral perfusion, including increased sympathetic tone and increased vascular stiffness. Recently, data suggest an important role of the endothelium for perfusion of skeletal muscle in heart failure. Endothelium-dependent dilation of resistance vessels is blunted in patients with severe chronic heart failure. Conceivably, this abnormality may be involved in the impaired reactive hyperemia in patients with chronic heart failure. Moreover, alterations of skeletal muscle emerge in chronic heart failure contributing to reduced exercise performance. Both endothelial dysfunction and alterations of skeletal muscle appear to be reversible with chronic ACE-inhibitor therapy and/or physical training.
引用
收藏
页码:13 / 16
页数:4
相关论文
共 50 条
  • [41] CARDIOMYOPLASTY FOR HEART-FAILURE
    ELOAKLEY, RM
    HOOPER, TL
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 1992, 48 (07): : 355 - 356
  • [42] DIURETICS IN HEART-FAILURE
    ZATUCHNI, J
    LANCET, 1986, 2 (8515): : 1102 - 1103
  • [43] CONGESTIVE HEART-FAILURE
    SPRITZER, N
    BODANESE, LC
    REVISTA BRASILEIRA DE MEDICINA, 1989, 46 : 57 - &
  • [44] INTRACTABLE HEART-FAILURE
    FLYNN, JT
    FREDRICKS, RN
    EICHLER, HL
    BATILLAS, J
    COPPERSMITH, HH
    BLACKMAN, NS
    WAGNER, BM
    POPICK, AJ
    NEW YORK STATE JOURNAL OF MEDICINE, 1975, 75 (08) : 1238 - 1246
  • [45] HEART-FAILURE IN THE ELDERLY
    HENDERSON, AH
    GERONTOLOGY, 1983, 29 (05) : 353 - 360
  • [46] CONGESTIVE HEART-FAILURE
    BERTEL, O
    KAUFMANN, U
    THERAPEUTISCHE UMSCHAU, 1990, 47 (08) : 686 - 692
  • [47] DIGITALIS IN HEART-FAILURE
    COHN, JN
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1984, 251 (11): : 1489 - 1489
  • [48] PULMONARY HEART-FAILURE
    不详
    LANCET, 1947, 253 (SEP20): : 439 - 440
  • [49] TRICYCLICS AND HEART-FAILURE
    DALACK, GW
    ROOSE, SP
    GLASSMAN, AH
    AMERICAN JOURNAL OF PSYCHIATRY, 1991, 148 (11): : 1601 - 1601
  • [50] THE DEFINITION OF HEART-FAILURE
    DENOLIN, H
    KUHN, H
    KRAYENBUEHL, HP
    LOOGEN, F
    REALE, A
    EUROPEAN HEART JOURNAL, 1983, 4 (07) : 445 - 448